Prof Timothy IllidgeBSc PhD FRCP FRCR FRCPath

Professor of Targeted Therapy & Oncology

Full contact details
View graph of relations

Publications

  1. 2019
  2. Published

    Immunogenic Effects of Radiotherapy for Bladder Cancer

    Walshaw, R. C., Roberts, J., Swan, J., Honeychurch, J., Choudhury, A. & Illidge, T. M., Feb 2019, In : Clinical Oncology. 31, 2, p. E26-E26

    Research output: Contribution to journalMeeting Abstract

  3. Published

    Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    ECHELON-2 Study Group, 19 Jan 2019, In : Lancet (London, England). 393, 10168, p. 229-240 12 p.

    Research output: Contribution to journalArticle

  4. Published

    Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom

    Bröckelmann, P. J., Mcmullen, S., Wilson, J. B., Mueller, K., Goring, S., Stamatoullas, A., Zagadailov, E., Gautam, A., Huebner, D., Dalal, M. & Illidge, T., 1 Jan 2019, In : British Journal of Haematology. 184, 2, p. 202-214 13 p.

    Research output: Contribution to journalArticle

  5. Published

    Evaluation of apoptosis imaging biomarkers in a genetic model of cell death

    Vassileva, V., Stribbling, S. M., Barnes, C., Carroll, L., Braga, M., Abrahams, J., Heinzmann, K., Haegeman, C., MacFarlane, M., Simpson, K. L., Dive, C., Honeychurch, J., Illidge, T. M. & Aboagye, E. O., 2019, In : EJNMMI Research. 9, 18.

    Research output: Contribution to journalArticle

  6. Published

    Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma

    Eskian, M., Khorasanizadeh, M. H., Zinzani, P. L., Illidge, T. M. & Rezaei, N., 2019, In : International Reviews of Immunology. 38, 2, p. 79-91 13 p.

    Research output: Contribution to journalReview article

  7. Published

    Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study

    Barrington, S. F., Phillips, E. H., Counsell, N., Hancock, B., Pettengell, R., Johnson, P., Townsend, W., Culligan, D., Popova, B., Clifton-Hadley, L., McMillan, A., Hoskin, P., O'Doherty, M. J., Illidge, T. & Radford, J., 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. p. JCO1801799

    Research output: Contribution to journalArticle

  8. Published

    The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper

    British Society for Haematology Guidelines, 2019, In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  9. 2018
  10. Published

    British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018

    Gilson, D., Whittaker, S. J., Child, F. J., Scarisbrick, J. J., Illidge, T. M., Parry, E. J., Mohd Mustapa, M. F., Exton, L. S., Kanfer, E., Rezvani, K., Dearden, C. E. & Morris, S. L., 17 Dec 2018, In : The British journal of dermatology.

    Research output: Contribution to journalArticle

  11. Published

    An investigation into the effects of prior irradiation to the tumour mass on murine TIL expansion

    Azizi, A., Cheadle, E., Popple, A. & Illidge, T., Dec 2018, In : Annals of Oncology. 29

    Research output: Contribution to journalMeeting Abstract

  12. E-pub ahead of print

    Clinical Development of Novel Drug-Radiotherapy Combinations

    Ahmad, S. S., Crittenden, M. R., Tran, P. T., Kluetz, P. G., Blumenthal, G. M., Bulbeck, H., Baird, R. D., Williams, K. J., Illidge, T., Hahn, S. M., Lawrence, T. S., Spears, P. A., Walker, A. J. & Sharma, R. A., 29 Nov 2018, In : Clinical cancer research : an official journal of the American Association for Cancer Research.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...16 Next